ArticleFrontiers in pain research (Lausanne, Switzerland)2026
Peak alpha frequency is associated with pain severity in Long COVID patients with new-onset chronic pain.
Article in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peak alpha frequency is associated with pain severity in Long COVID patients with new-onset chronic pain.Frontiers in pain research (Lausanne, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: New-onset chronic pain is a common and debilitating symptom of Long COVID (LC) that remains not fully understood in terms of pathophysiology and therapeutic targets. A growing body of evidence in chronic pain syndromes similar to LC demonstrates an association between EEG alpha oscillatory activity and the experience of pain, with clinical studies showing maladaptive changes, particularly a slowing of alpha activity. Aims: This study aims to investigate the association between EEG alpha oscillatory activity and pain perception in new-onset LC-chronic pain. Methods: We recruited 31 individuals (20 females) with a clinical diagnosis of LC reporting new-onset chronic pain and 31 healthy pain-free age- and sex-matched controls. Participants completed questionnaires regarding symptoms and psychological functioning prior to recording eyes-open resting-state EEG. Peak alpha frequency (PAF) and alpha band (8-13 Hz) spectral power were extracted from EEG signals. Results: Lower PAF over the posterior scalp region was significantly associated with higher LC-chronic pain severity when controlling for age, depression and the use of centrally acting medication. This finding was consistent across PAF estimation methods. No differences in PAF were observed between the LC patient group and the healthy pain-free control group. Alpha power did not differ between groups and was not associated with pain severity. Discussion: Together, these findings suggest that PAF may index individual differences in pain severity within LC-associated chronic pain, although the absence of overall patient-control differences indicates that PAF should not be interpreted as a disease-specific biomarker and warrants further longitudinal research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.